Bio Essence Corporation (BIOE)
OTCMKTS · Delayed Price · Currency is USD
0.1900
0.00 (0.00%)
Sep 4, 2026, 4:00 PM EST
Bio Essence Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2.91 | 1.9 | 0.32 | - | 0.62 | 0.89 | |
Revenue Growth | 416.63% | 485.78% | - | - | -30.00% | -7.38% |
Cost of Revenue | 0.88 | 0.47 | 0.11 | - | 0.29 | 0.59 |
Gross Profit | 2.03 | 1.43 | 0.22 | - | 0.33 | 0.3 |
Selling, General & Admin | 0.49 | 0.53 | 0.68 | 0.35 | 0.84 | 1.15 |
Operating Expenses | 0.49 | 0.53 | 0.68 | 0.35 | 0.84 | 1.16 |
Operating Income | 1.54 | 0.9 | -0.46 | -0.35 | -0.51 | -0.86 |
Interest Expense | -0 | -0 | -0 | -0 | -0.01 | -0.04 |
Interest & Investment Income | 0 | - | - | - | - | - |
Other Non Operating Income (Expenses) | -0 | -0 | -0.05 | -0.06 | -0 | 0.01 |
EBT Excluding Unusual Items | 1.54 | 0.9 | -0.51 | -0.4 | -0.53 | -0.89 |
Asset Writedown | - | - | -1.05 | - | - | - |
Other Unusual Items | - | - | - | - | - | 0.24 |
Pretax Income | 1.54 | 0.9 | -1.56 | -0.4 | -0.53 | -0.64 |
Income Tax Expense | 0.02 | 0 | 0 | 0 | 0 | 0 |
Earnings From Continuing Operations | 1.52 | 0.9 | -1.57 | -0.4 | -0.53 | -0.65 |
Earnings From Discontinued Operations | - | - | 0.26 | -0.57 | -0.28 | - |
Net Income | 1.52 | 0.9 | -1.31 | -0.97 | -0.81 | -0.65 |
Net Income to Common | 1.52 | 0.9 | -1.31 | -0.97 | -0.81 | -0.65 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 44 | 38 | 38 | 34 | 33 | 33 |
Shares Outstanding (Diluted) | 44 | 38 | 38 | 34 | 33 | 33 |
Shares Change | 16.94% | - | 11.94% | 2.86% | - | -0.08% |
EPS (Basic) | 0.03 | 0.02 | -0.03 | -0.03 | -0.02 | -0.02 |
EPS (Diluted) | 0.03 | 0.02 | -0.03 | -0.03 | -0.02 | -0.02 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1.08 | 1.57 | 0.62 | -1.03 | -0.71 | -1.41 |
Free Cash Flow Per Share | 0.02 | 0.04 | 0.02 | -0.03 | -0.02 | -0.04 |
Gross Margin | 69.68% | 75.28% | 67.01% | - | 52.82% | 33.60% |
Operating Margin | 52.86% | 47.43% | -141.83% | - | -82.23% | -96.57% |
Profit Margin | 52.12% | 47.23% | -404.02% | - | -130.26% | -72.92% |
Free Cash Flow Margin | 36.95% | 82.73% | 192.59% | - | -113.74% | -159.19% |
EBITDA | 1.64 | 0.9 | -0.46 | -0.34 | -0.5 | -0.82 |
EBITDA Margin | 56.42% | 47.44% | -141.47% | - | -79.90% | -92.54% |
D&A For EBITDA | 0.1 | 0 | 0 | 0 | 0.01 | 0.04 |
EBIT | 1.54 | 0.9 | -0.46 | -0.35 | -0.51 | -0.86 |
EBIT Margin | 52.86% | 47.43% | -141.83% | - | -82.23% | -96.57% |
Effective Tax Rate | 1.32% | 0.09% | - | - | - | - |
Revenue as Reported | 2.91 | 1.9 | 0.32 | - | 0.62 | 0.89 |